Sonnet Biotherapeutics Stock Forecast - Relative Strength Index
| SONN Stock | USD 2.90 0.02 0.68% |
Sonnet Stock Forecast is based on your current time horizon. Although Sonnet Biotherapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Sonnet Biotherapeutics' systematic risk associated with finding meaningful patterns of Sonnet Biotherapeutics fundamentals over time.
Sonnet |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 31.01 | 31.01 |
| Check Sonnet Biotherapeutics Volatility | Backtest Sonnet Biotherapeutics | Information Ratio |
Sonnet Biotherapeutics Trading Date Momentum
| On November 21 2024 Sonnet Biotherapeutics Holdings was traded for 2.90 at the closing time. The top price for the day was 3.08 and the lowest listed price was 2.88 . The trading volume for the day was 63.5 K. The trading history from November 21, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.69% . |
| Compare Sonnet Biotherapeutics to competition |
Other Forecasting Options for Sonnet Biotherapeutics
For every potential investor in Sonnet, whether a beginner or expert, Sonnet Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sonnet Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sonnet. Basic forecasting techniques help filter out the noise by identifying Sonnet Biotherapeutics' price trends.Sonnet Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sonnet Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Sonnet Biotherapeutics could also be used in its relative valuation, which is a method of valuing Sonnet Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sonnet Biotherapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sonnet Biotherapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sonnet Biotherapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sonnet Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Sonnet Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sonnet Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Sonnet Biotherapeutics stock market strength indicators, traders can identify Sonnet Biotherapeutics Holdings entry and exit signals to maximize returns.
Sonnet Biotherapeutics Risk Indicators
The analysis of Sonnet Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sonnet Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sonnet stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.76 | |||
| Standard Deviation | 6.83 | |||
| Variance | 46.61 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock: Check out Historical Fundamental Analysis of Sonnet Biotherapeutics to cross-verify your projections. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.50) | Return On Assets (0.97) | Return On Equity (2.65) |
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.